logo
#

Latest news with #quarterlyProfit

India's Samvardhana Motherson misses quarterly profit estimates as global car sales decline
India's Samvardhana Motherson misses quarterly profit estimates as global car sales decline

Reuters

time4 days ago

  • Automotive
  • Reuters

India's Samvardhana Motherson misses quarterly profit estimates as global car sales decline

May 29 (Reuters) - Samvardhana Motherson ( opens new tab, India's top auto parts maker by market capitalisation, missed quarterly profit estimates on Thursday, hurt by weak global vehicle sales. The company's consolidated profit dropped 23% to 10.51 billion rupees (about $123 million) for the quarter ended March 31. Analysts, on average, expected a profit of 10.95 billion rupees, according to data compiled by LSEG. Revenue grew 8% to 293.17 billion rupees, ahead of analysts' forecast of 287.85 billion rupees. Shares of the company hit an intraday high after results and closed 2.3% higher. For detailed earnings highlights, click (Full story). European car sales have been affected due to competition from China, the uncertainty around a 25% U.S. import tariff, and high costs. Samvardhana Motherson counts German auto majors such as Mercedes-Benz ( opens new tab, Volkswagen , Audi and BMW ( opens new tab among its top customers in Europe. Earlier this month, peer Sona BLW ( opens new tab reported a 10.4% quarterly profit rise on strong order book, but flagged a negative impact from the U.S. tariffs on short-term demand in the global auto industry. PEER COMPARISON * Mean of analysts' ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell ** Ratio of the stock's last close to analysts' mean price target; a ratio above 1 means the stock is trading above the PT JANUARY-MARCH STOCK PERFORMANCE -- All data from LSEG -- $1 = 85.4620 Indian rupees

India's Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
India's Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs

Reuters

time22-05-2025

  • Business
  • Reuters

India's Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs

May 22 (Reuters) - Sun Pharmaceutical ( opens new tab, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases. The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31. ($1 = 85.9500 Indian rupees)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store